To include your compound in the COVID-19 Resource Center, submit it here.

V-1 Immunitor: Phase II

In a placebo-controlled Thai Phase II trial in 35 HIV-negative volunteers, 20

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE